[1] AOU Careggi,Center for Research and Innovation of Myeloproliferative Neoplasms (CRIMM)
[2] University of Florence,Laboratorio Congiunto and Department of Experimental and Clinical Medicine
[3] University of Texas MD Anderson Cancer Center,Division of Cancer Medicine
[4] Johannes Wesling Medical Center,University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care
[5] University of Bochum,UKRUB
[6] Incyte Corporation,Centre d’Investigations Cliniques (INSERM CIC 1427)
[7] Novartis Pharmaceuticals Corporation,undefined
[8] Hôpital Saint-Louis,undefined
[9] Université Paris Diderot,undefined